体外膜氧合中低剂量与标准抗凝方案比较
该回顾性研究比较了成人VA-ECMO支持中低剂量与标准肝素抗凝方案。低肝素组(52例)在插管后不再持续肝素输注,标准组(50例)维持ACT 180-220秒。低肝素组严重出血并发症(11.5%)低于标准组(32%,p=0.012),且成功脱离ECMO比例更高(50% vs 36%,p=0.05)。
要点
- 低肝素方案在VA-ECMO中安全,可减少严重出血。
- 低肝素组严重出血11.5%,标准组32%,差异显著。
- 低肝素组成功脱离ECMO比例更高(50% vs 36%)。
核心结论
- 在VA-ECMO成人患者中,低肝素维持抗凝是安全的,可能降低严重出血及相关并发症风险。
研究设计与样本
- 回顾性比较研究,纳入2011年11月至2016年11月在Rush大学医学中心接受VA-ECMO的成人患者,低肝素组52例,标准肝素组50例。
主要发现
- 低肝素组成功脱离ECMO 26例(50%),标准组18例(36%),p=0.05。
- 插管部位出血低肝素组11例(21%),标准组21例(42%)。
- 手术部位出血低肝素组11例(21%),标准组18例(36%)。
- 严重出血并发症低肝素组11.5%,标准组32%,p=0.012。
- 两组疾病严重程度相似(死亡概率模型59% vs 62.9%,p=0.08)。
关键数值与推荐
- 标准组:初始肝素5000 U,随后维持ACT目标180-220秒。
- 低肝素组:插管时给予标准肝素负荷5000 U,后续无持续肝素输注。
- 所有患者使用CentriMag泵、Quadrox氧合器和肝素涂层管路。
临床怎么用
- 对于VA-ECMO成人患者,可考虑采用低肝素抗凝策略以减少严重出血风险。
局限性
- 回顾性设计,样本量有限,来自单中心,结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bleeding and need for blood products are major complications associated with extracorporeal membrane oxygenation (ECMO) use. This study evaluated bleeding complications with low and standard heparinization protocols in the maintenance of venoarterial (VA)-ECMO. METHODS: A retrospective comparison was performed of 2 methods of heparinization in a contemporaneous series of adult patients supported with VA-ECMO at Rush University Medical Center, between November 2011 and November 2016. CentriMag (Thoratec, Pleasanton, CA) pumps, Quadrox (Maquet, Wayne, NJ) oxygenators, and heparin-bonded circuitry were used in all patients. Group 1 was a control group of 50 patients who had ECMO support with an initiation dose of 5,000 U of heparin, followed by standard heparinization at a goal activated clotting time of 180 to 220 seconds. Group 2 comprised 52 adult patients supported with a "low heparin protocol" ECMO, receiving a standard heparin bolus of 5,000 U for cannulation but without subsequent, ongoing heparin administration. Acuity of illness was similar in both groups as assessed by the Mortality Probability Model (59% in Group 1 vs 62.9% in Group 2, p = 0.08). Data were submitted to the Extracorporeal Life Support Organization prospectively. Clots in the circuit, limb ischemia, oxygenator failure, and embolic complications were recorded. RESULTS: Weaning off ECMO was successful in 26 patients (50%) in Group 2 compared with 18 (36%) in Group 1 (p = 0.05). Hemorrhage from the cannulation site occurred in 11 (21%) in Group 2 vs 21 (42%) in Group 1 and from the surgical site in 11 (21%) in Group 2 vs 18 (36%) in Group 1. Severe bleeding complications were higher in the control group (Group 1, 32%) compared with Group 2 (11.5%; p = 0.012). CONCLUSIONS: Maintenance with low heparin is safe in patients supported by VA-ECMO. This strategy may reduce risk of severe bleeding and associated complications.
引用
- Raman J, Alimohamed M, Dobrilovic N, et al. A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation. J Heart Lung Transplant. 2019. PMID: 30744940. doi:10.1016/j.healun.2019.01.1313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。